BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16256939)

  • 1. Targeted inhibition of alphavbeta3 integrin with an RNA aptamer impairs endothelial cell growth and survival.
    Mi J; Zhang X; Giangrande PH; McNamara JO; Nimjee SM; Sarraf-Yazdi S; Sullenger BA; Clary BM
    Biochem Biophys Res Commun; 2005 Dec; 338(2):956-63. PubMed ID: 16256939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agglucetin, a tetrameric C-type lectin-like venom protein, regulates endothelial cell survival and promotes angiogenesis by activating integrin alphavbeta3 signaling.
    Wang WJ
    Biochem Biophys Res Commun; 2008 May; 369(2):753-60. PubMed ID: 18312855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain.
    O E; Kim HK; Hong SH; Kim CK; Hong YK; Joe YA
    Oncol Rep; 2008 Sep; 20(3):631-6. PubMed ID: 18695916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of betaig-h3, via alphavbeta3 integrin.
    Nam JO; Jeong HW; Lee BH; Park RW; Kim IS
    Cancer Res; 2005 May; 65(10):4153-61. PubMed ID: 15899806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein(a) stimulates vascular endothelial cell growth and migration and signals through integrin alphaVbeta3.
    Liu L; Craig AW; Meldrum HD; Marcovina SM; Elliott BE; Koschinsky ML
    Biochem J; 2009 Mar; 418(2):325-36. PubMed ID: 18821851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an active site on the laminin alpha4 chain globular domain that binds to alphavbeta3 integrin and promotes angiogenesis.
    Lian J; Dai X; Li X; He F
    Biochem Biophys Res Commun; 2006 Aug; 347(1):248-53. PubMed ID: 16824487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
    Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
    Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase D1 regulates VEGF-A-induced alphavbeta3 integrin trafficking and endothelial cell migration.
    di Blasio L; Droetto S; Norman J; Bussolino F; Primo L
    Traffic; 2010 Aug; 11(8):1107-18. PubMed ID: 20477989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronate inhibits alphavbeta3 and alphavbeta5 integrin cell surface expression in endothelial cells.
    Bellahcène A; Chaplet M; Bonjean K; Castronovo V
    Endothelium; 2007; 14(2):123-30. PubMed ID: 17497369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
    Chen YJ; Wei YY; Chen HT; Fong YC; Hsu CJ; Tsai CH; Hsu HC; Liu SH; Tang CH
    J Cell Physiol; 2009 Oct; 221(1):98-108. PubMed ID: 19475568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation.
    Ruseva Z; Geiger PX; Hutzler P; Kotzsch M; Luber B; Schmitt M; Gross E; Reuning U
    Exp Cell Res; 2009 Jun; 315(10):1759-71. PubMed ID: 19371633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Design and activity determination of small molecular inhibitors of integrin alphavbeta3].
    Ji Q; Zhou Y; Peng H; Huang N; Qi J; Xiong DS; Gao YD; Yang M; Yang CZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Jun; 29(3):347-52. PubMed ID: 17633460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of macrophages on the biological behaviors and VEGF receptor mRNA, Hoxb2 mRNA, and integrin alphavbeta3 expressions of vascular endothelial cells].
    Liu L; Liu XS; Zhang XQ; Ming J; Xu H; Cheng TM
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):148-51. PubMed ID: 15698991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and functional differences between human liver cancer endothelial cells and liver sinusoidal endothelial cells.
    Wu LQ; Zhang WJ; Niu JX; Ye LY; Yang ZH; Grau GE; Lou JN
    J Vasc Res; 2008; 45(1):78-86. PubMed ID: 17901709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models.
    Albert JM; Cao C; Geng L; Leavitt L; Hallahan DE; Lu B
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1536-43. PubMed ID: 16863930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of alphav integrin in osteoprotegerin-induced endothelial cell migration and proliferation.
    Kobayashi-Sakamoto M; Isogai E; Hirose K; Chiba I
    Microvasc Res; 2008 Nov; 76(3):139-44. PubMed ID: 18656492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of human Thy-1 (CD 90) with the integrin alphavbeta3 (CD51/CD61): an important mechanism mediating melanoma cell adhesion to activated endothelium.
    Saalbach A; Wetzel A; Haustein UF; Sticherling M; Simon JC; Anderegg U
    Oncogene; 2005 Jul; 24(29):4710-20. PubMed ID: 15897908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin promotes brain capillary endothelial cell survival and proliferation through alpha5beta1 and alphavbeta3 integrins via MAP kinase signalling.
    Wang J; Milner R
    J Neurochem; 2006 Jan; 96(1):148-59. PubMed ID: 16269008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin alphavbeta3 mediates upregulation of epidermal growth-factor receptor expression and activity in human ovarian cancer cells.
    Lössner D; Abou-Ajram C; Benge A; Reuning U
    Int J Biochem Cell Biol; 2008; 40(12):2746-61. PubMed ID: 18577466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.